Irish Pilot Allows Pharma To Seek National Scientific Advice On Specific Therapeutic Areas
The Irish regulator is offering national scientific and regulatory advice to drug companies on a pilot basis as part of a long-term project to support innovation.
You may also be interested in...
The newly established EU Innovation Network aims to increase the visibility of the support being offered by national competent authorities to innovative medicinal products in member states, and help boost the delivery of novel medicines to patients.
Revised labeling requirements for unauthorized investigational and auxiliary medicinal products under the EU Clinical Trial Regulation have been published in the Official Journal.
The European Medicines Agency has partnered with eight institutions having access to real-world healthcare data to enable its DARWIN EU project to deliver real-world evidence to the EU medicines regulatory network when needed.